Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Early detection of symptoms using electronic patient-reported outcomes and a Fitbit to optimise care in metastatic breast cancer: study protocol of the SYMPHA trial

Therapeutic strategies for patients with metastatic breast cancer (mBC) are aimed at prolonging survival while preserving health-related quality of life (HRQoL). Current systemic therapies, however, are frequently associated with severe toxicities that impair HRQoL. Early detection of symptoms related to treatmen...

L. Folkert, C. V. D. van den Hurk, C. Drossaert et al. · 0 citations
Open access Aug 2026

Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.

BACKGROUND The randomised phase III OlympiA trial (NCT02032823) compared 1 year of adjuvant olaparib (oral poly-(ADP-ribose) polymerase [PARP] inhibitor) to placebo in 1,836 patients with pathogenic/likely pathogenic BRCA1 or BRCA2 (gBRCApv) germline variants and high-risk human epidermal growth factor receptor 2 (HER2...

J. Garber, D. Cameron, C. Campbell et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.